---
document_datetime: 2025-09-25 11:32:31
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/lacosamide-adroiq-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: lacosamide-adroiq-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.6781072
conversion_datetime: 2025-12-20 13:59:40.777485
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Lacosamide Adroiq

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber    | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | A.ADMINISTRATIVECHANGES-A.1 Change | 23/09/2025                          |                                          | SmPC,                           |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000297357   | in the name and/or address of the marketing authorisation holder - Accepted                                                                                                                                                                                                                                                                                                                                                                            |            |     | Labelling and PL   |                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|-------------------|
| Variation type IB / | B.1I.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier)-B.II.e.7.bReplacement or addition of a supplier-Accepted                                                                                                                                                                                                                                                                                                | 26/06/2025 | N/A |                    | EMA/VR/0000274344 |
| Variation type IB / | B.II.d.2Changeintestprocedureforthe finishedproduct-B.II.d.2.aMinorchanges to an approved test procedure - Accepted                                                                                                                                                                                                                                                                                                                                    | 23/06/2025 | N/A |                    | EMA/VR/0000275747 |
| Variation type IA / | This was an application for a group of variations. B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier)-B.II.e.7.b Replacement or additionofasupplier-Refused B.II.d.2Changeintestprocedurefor the finishedproduct-B.II.d.2.aMinorchanges to an approved testprocedure-Refused B.II.d.2 Change in test procedure for the finished product - B.1I.d.2.a Minor changes to an approved test procedure- Accepted | 25/04/2025 | N/A |                    | EMA/VR/0000264666 |